Applications, hearings, determinations, etc.: Chiragene, Inc.,

[Federal Register: March 5, 1999 (Volume 64, Number 43)]

[Notices]

[Page 10724]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr05mr99-97]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances; Notice of Registration

By Notice dated October 1, 1998, and published in the Federal Register on October 9, 1998, (63 FR 54491), Chiragene, Inc., 7 Powder Horn Drive, Warren, New Jersey 07509, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed below:

Drug

Schedule

2,5-Dimethoxyamphetamine (7396)............ I Phenylacetone (8501)....................... II

By letter dated February 11, 1998, Chiragene, Inc. has withdrawn its application for registration to import 2,5-Dimethoxyamphetamine. Therefore, 2,5-Dimethoxyamphetamine is hereby deleted from the firm's application for registration as an importer.

The firm plans to import the phenylacetone to manufacture amphetamine.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, section 823(a) and determined that the registration of Chiragene, Inc. to import the listed controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. Therefore, pursuant to section 1008(a) of the Controlled Substances Import and Export Act and in accordance with Title 21, Code of Federal Regulations, section 1311.42, the above firm is granted registration as an importer of phenylacetone. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 99-5404Filed3-4-99; 8:45 am]

BILLING CODE 4410-09-M

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT